Evidence on pharmaceutical services related to the treatment of Covid-19: Integrative review

Authors

DOI:

https://doi.org/10.33448/rsd-v11i12.34300

Keywords:

Pharmacist; Covid-19; SARS-CoV-2; Pharmaceutical services; Pharmaceutical interventions.

Abstract

Objective: To retrieve scientific evidence on pharmaceutical services related to the treatment of Covid-19. Methodology: Integrative Review, with a time frame from 2020 to 2022. Results: Sixteen studies were retrieved from different regions of the world: Brazil (3), China (3), Egypt (1), United Kingdom (1), Kosovo (1), United Arab Emirates (1), Poland (1), Czech Republic (1), Portugal (1), Jordan (1) and Lebanon (1). It is observed that the studies do not report in depth issues related to equity, such as location, race, occupation, sex, religion, education, social capital and economic status. Conclusion: The prevention and treatment of Covid-19 have an intrinsic link with pharmaceutical care through the provision of pharmaceutical services, such as the pharmaceutical care performed by the pharmacist. The pandemic has brought with it changes and advances in health that promote the dissemination of active/passive, face-to-face/remote information, such as telepharmacy guidance services; one of the main means of disseminating knowledge about the rational use of medicines, based on scientific evidence on the prophylaxis and treatment of Covid-19.

References

Alsayed, A. R., Halloush, S., Hasoun, L., Alnatour, D., Al-Dulaimi, A., Alnajjar, M. S., & Khader, H. A. (2022). Perspectives of the community in the developing countries toward telemedicine and pharmaceutical care during the Covid-19 pandemic. Pharmacy Practice, 20(1), 1-12. 10.18549/PharmPract.2022.1.2618

Bahlol, M., & Dewey, R. S. (2021). Pandemic preparedness of community pharmacies for Covid-19. Research in Social and Administrative Pharmacy, 17(1), 1888-1896. 1-s2.0-S1551741120305015-main.pdf

Bastos, J. L. D., & Duquia, R. P. (2007). Um dos delineamentos mais empregados em epidemiologia: estudo transversal. Scientia Medica. 17(4):229-232. Umdosdelineamentosmaisempregadosemepidemiologia (1).pdf

Brasil. (2020). Folha informativa–Covid-19: doença causada pelo novo coronavírus. https://www.paho.org/bra/index.php?option=com_content&view=article&id=6101:Covid19&Itemid=875.

Brasil. (2021). Ministério da Saúde. Secretaria de Ciência, Tecnologia, Inovação e Insumos Estratégicos em Saúde. Departamento de Gestão e Incorporação de Tecnologias em Saúde. Diretrizes metodológicas : elaboração de revisão sistemática e meta-análise de ensaios clínicos randomizados [recurso eletrônico] – Brasília : Ministério da Saúde. 93 p. : il. ISBN 978-65-5993-021-0. http://bvsms.saude.gov.br/bvs/publicacoes/diretrizes_elaboracao_revisao_sistematica_meta-analise.pdf

BRASIL. Ministério da Saúde. DATASUS. (2022). Coronavírus no Brasil. Painel coronavírus: Coronavírus Brasil 2020 (saude.gov.br)

Costa, S., Romão, M., Mendes, M., Horta, M. R., Rodrigues, A. T., Carneiro, A. V., & Naci, H. (2022). Pharmacy interventions on Covid-19 in Europe: Mapping current practices and a scoping review. Research in Social and Administrative Pharmacy, 18(8), 2022, 3338-3349. ISSN 1551-7411. https://doi.org/10.1016/j.sapharm.2021.12.003

Dantas, E. S. O. (2021). Saúde mental dos profissionais de saúde no Brasil no contexto da pandemia por Covid-19. Interface-Comunicação, Saúde, Educação, 25, 1-9. https://www.scielo.br/j/icse/a/rCWq43y7mydk8Hjq5fZLpXg/?format=pdf&lang=pt

Ercole, F. F., Melo, L. S., & Alcoforado, C. L. G. C. (2014). Revisão integrativa versus revisão sistemática. Rev Min Enferm.18(1), 9-12. http://www.dx.doi.org/10.5935/1415-2762.20140001

Fagherazzi, G., Goetzinger, C., Rashid, M. A., Aguayo, G. A., & Huiart, L. (2020). Estratégias digitais de saúde para combater o Covid-19 em todo o mundo: desafios, recomendações e um edital de trabalho. Journal of Medical Internet Research, 22(6), e19284. 10.2196/19284

Galvão, C. M., Sawada, N. O., & Mendes, I. A. C. (2003). A busca das melhores evidências. Rev Esc Enferm USP.; 37(4), 43-50. ISSN 1980-220X. https://doi.org/10.1590/S0080-62342003000400005.

Galvão, T. F., Pansani, T. S. A., & Harrad, D. (2015). Principais itens para relatar Revisões sistemáticas e Meta-análises: A recomendação PRISMA. Epidemiologia e Serviços de Saúde [online]. 24(2), 335-342. ISSN 2237-9622. https://doi.org/10.5123/S1679-49742015000200017.

Gorbalenya, A. E., Baker, S.C., Baric, R. S., de Groot, R. J., Drosten, C., Gulyaeva, A. A., & Ziebuhr, J. (2020). Coronavírus grave relacionado à síndrome respiratória aguda: A espécie e seus vírus – uma declaração do Coronavirus Study Group. BioRxiv. doi: https://doi.org/10.1101/2020.02.07.937862

Greenhalgh, T., Koh, G. C. H., & Car, J. (2020). Covid-19: a remote assessment in primary care. BMJ, 25;368:m1182. 10.1136/bmj.m1182. PMID: 32213507.

Hoti, K., Jakupi, A., Hetemi, D., Raka, D., Hughes, J., & Desselle, S. (2020). Provision of community pharmacy services during Covid-19 pandemic: a cross sectional study of community pharmacists’ experiences with preventative measures and sources of information. International journal of clinical pharmacy, 42(4):1197-1206. 10.1007/s11096-020-01078-1

Ibrahim, O. M., Ibrahim, R. M., Z., Al Meslamani, A., & Al Mazrouei, N. (2020). Role of telepharmacy in pharmacist counselling to coronavirus disease 2019 patients and medication dispensing errors. Journal of Telemedicine and Telecare 0(0), 1–10. https://doi.org/10.1177/1357633X20964347

Karout, S., Khojah, H. M., Itani, R., Jaffal, F., & El-Lakany, A. (2022). Assessing the pharmaceutical care provision to suspected Covid-19 patients in community pharmacies: a simulated patient study. BMC health services research, 22(1), 1-8. 10.1186/s12913-022-07870-1

Li, H., Zheng, S., Liu, F., Liu, W., & Zhao, R. (2021). Fighting against Covid-19: innovative strategies for clinical pharmacists. Research in Social and Administrative Pharmacy, 17(1), 1813-1818. https://doi.org/10.1016/j.sapharm.2020.04.003

Maříková, M., Josková, V., Halvová, P., Rozsívalová, P., & Kapla, J. (2021). Clinical pharmaceutical care engagement at the department of infectious diseases during the first Covid-19 pandemic wave–single centre experience. Klin Farmakol Farm 2021; 35(1), 6–11. https://www.researchgate.net/publication/350779234

Mendes, K. D. S., Silveira, R. C. C. P., & Galvão, C. M. (2008). Revisão integrativa: método de pesquisa para a incorporação de evidências na saúde e na enfermagem. Texto Contexto Enferm, 17(4), 758-64. ISSN 1980-265X

Merks, P., Jakubowska, M., Drelich, E., Świeczkowski, D., Bogusz, J., Bilmin, K., & Vaillancourt, R. (2021). The legal extension of the role of pharmacists in light of the Covid-19 global pandemic. Research in Social and Administrative Pharmacy, 17(1), 1807-1812.10.1016/j.sapharm.2020.05.033

Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group. (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(7), e1000097.10.1371/journal.pmed1000097

Murad, M. H., Asi, N., Alsawas, M., & Alahdab, F. (2016). New evidence pyramid. Evid Based Med, 21(4), 125-127. 10.1136/ebmed-2016-110401. untitled (bmj.com)

Niu, J., Chen, H., Chen, K., Liu, Y., Ju, F., Xue, T., & Huang, J. (2020). Effect of pharmaceutical care on the treatment of Covid-19: a protocol for systematic review and meta-analysis. Medicine, 99(48), e23377. 10.1097/MD.0000000000023377

Noronha, K. V. M. D. S., Guedes, G. R., Turra, C. M., Andrade, M. V., Botega, L., Nogueira, D., & Ferreira, M. F. (2020). Pandemia por Covid-19 no Brasil: análise da demanda e da oferta de leitos hospitalares e equipamentos de ventilação assistida segundo diferentes cenários. Cad. Saúde Pública, 36(6), e00115320. doi: 10.1590/0102-311X00115320

Oliveira, A. R (2020). Covid-19 is causing the collapse of Brazil’s national health service BMJ, 370, m3032. doi:10.1136/bmj.m3032

Oliveira, M. A., Vellarde, G. C., & Sá, R. A. M. (2015). Entendendo a pesquisa clínica IV: estudos de caso controle. FEMINA. 43(4), 175-180. a5310.pdf (bvs.br)

Oliveira, M. A., Vellarde, G. C., & Sá, R. A.M. (2015). Entendendo a pesquisa clínica III: estudos de coorte. FEMINA. 43(3), 105-110. a5116.pdf (bvs.br)

Organização Mundial da Saúde (OMS). (2020). Modos de transmissão do vírus que causam Covid-19: implicações para recomendações de precaução do IPC: resumo científico, 29 de março de 2020 (nº WHO/2019-nCoV/Sci_Brief/Transmission_modes_2020.2). Organização Mundial da Saúde. WHO-2019-nCoV-Sci_Brief-Transmission_modes-2020.3-eng.pdf

Pará. Secretaria Executiva de Saúde do Estado do Pará. Painel Covid-19. (2022). Coronavírus – SESPA (saude.pa.gov.br); Coronavírus no Estado do Pará. Metabase (COVID-19.pa.gov.br): Monitoramento Covid-19

Passos, M. M. B., Castoldi, V. de M., & Soler, O. (2021). The role of the pharmacist in the Covid-19 pandemic: An integrative review. Research, Society and Development, 10(6), e27110615809. https://doi.org/10.33448/rsd-v10i6.15809

Prado, N. M. D. B. L., Carvalho, V. N., Nunes, F. G., Jesus, N. N. D., Santos, H. L. P. C. D., & Santos, A. M. D. (2021). Análise da produção científica sobre os serviços farmacêuticos comunitários no enfrentamento da pandemia pelo coronavírus. Saúde em Debate, 45, 129, 533-547, 10.1590/0103-1104202112921

Rother, E. T. (2007). Revisão sistemática versus revisão narrativa. Acta Paulista de Enfermagem [online], 20(2), v-vi. ISSN 1982-0194. https://doi.org/10.1590/S0103-21002007000200001.

Sethuraman, N., Jeremias, S. S., & Ryo, A. (2020). Interpretação de testes diagnósticos para SARS-CoV-2. Jama, 323(22), 2249-2251. 10.1001/jama.2020.8259

Shea, B. J., Grimshaw, J. M., Wells, G. A., Boers, M., Andersson, N., Hamel, C., Porter, A. C., Tugwell, P., Moher, D., & Bouter, L. M. (2007). Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol, 7, 10. PMID: 17302989. 10.1186/1471-2288-7-10

Silva, I. P., Araújo, M. R. L., Sousa Junior, J. R. T., Silva, A. S., Queiroz, L. M. D. Passos, M. M. B., & Soler, O. (2021). Profile of prescriptions of drugs for Covid-19 at the General Hospital of Unimed, Belém, Pará, Amazon. Research, Society and Development, [S. l.], 10(15), e123101522698. 10.33448/rsd-v10i15.22698

Song, Z., Hu, Y., Zheng, S., Yang, L., & Zhao, R. (2021). Hospital pharmacists’ pharmaceutical care for hospitalized patients with Covid-19: Recommendations and guidance from clinical experience. Research in Social and Administrative Pharmacy, 17(1), 2027-2031. https://doi.org/10.1016/j.sapharm.2020.03.027

Souza, D. D. O. (2020). O subfinanciamento do Sistema Único de Saúde e seus rebatimentos no enfrentamento da Covid-19. Physis: Revista de Saúde Coletiva, 30(3), e300313, 2020. http://dx.doi.org/10.1590/S0103-73312020300313

Tricco, A. C., Lillie, E., Zarin, W., O'Brien, K. K., Colquhoun, H., Levac, D., Moher, D., Peters, M. D., Horsley, T., Weeks, L., Hempel, S., et al. (2018). PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med.169(7), 467-473. doi:10.7326/M18-0850.

Visacri, M. B., Figueiredo, I. V., & de Mendonça Lima, T. (2021). Role of pharmacist during the Covid-19 pandemic: a scoping review. Research in social and administrative pharmacy, 17(1), 1799-1806. https://doi.org/10.1016/j.sapharm.2020.07.003

World Health Organization (WHO). (2020). Coronavirus (Covid-19) events as they happen. 2020. https://www. who. int/emergencies/diseases/novelcoronavirus-2019/events-as-they-happen.

World Health Organization (WHO). (2020). Director-General’s statement on IHR Emergency Committee on Novel Coronavirus (2019-nCoV). https://www.who.int/dg/speeches/detail/who-director-general-s-statement-on-ihr-emergency-committee-on-novel-coronavirus.

World Health Organization (WHO). (2020). Severe acute respiratory syndrome (SARS). https://www.who.int/csr/sars/en/

Yi, Z. M., Hu, Y., Wang, G. R., & Zhao, R. S. (2020). Mapping evidence of pharmacy services for Covid-19 in China. Frontiers in Pharmacology, 11, 555753. 10.3389/fphar.2020.555753

Zaidi, S. T. R., & Hasan, S. S. (2021). Personal protective practices and pharmacy services delivery by community pharmacists during Covid-19 pandemic: results from a national survey. Research in Social and Administrative Pharmacy, 17(1), 1832-1837. https://doi.org/10.1016/j.sapharm.2020.07.006

Downloads

Published

09/09/2022

How to Cite

COSTA, B. W. B. .; LIMA, G. C. de .; MACEDO, C. L. .; PEREIRA, C. F. .; SOLER, O. . Evidence on pharmaceutical services related to the treatment of Covid-19: Integrative review. Research, Society and Development, [S. l.], v. 11, n. 12, p. e126111234300, 2022. DOI: 10.33448/rsd-v11i12.34300. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/34300. Acesso em: 24 apr. 2024.

Issue

Vol. 11 No. 12

Section

Review Article

License

Copyright (c) 2022 Bruno Wesley Bezerra Costa; Gustavo Campos de Lima; Caio Leonardo Macedo; César Faial Pereira; Orenzio Soler

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.